Кардиоваскулярная терапия и профилактика, 2016 Aim. To study the significance of clinical parameters and cardiovascular risk factors (CVR) for restenosis development at long terms after percutaneous coronary intervention (PCI) as a possible displaying of neoatherosclerosis development (NA).Material ...
V. P. Mazaev +2 more
doaj +1 more source
Association of insulin resistance, insulin and leptin levels with coronary in-stent restenosis
The Egyptian Heart Journal, 2012 Background: In-stent restenosis remains the major limitation of coronary stent implantation. Leptin is a hormone strongly related to insulin resistance (IR).
Amira Shoukry +2 more
doaj +1 more source
An investigation into the influence of stent strut thickness on in-stent restenosis using the finite element method [PDF]
, 2005 In-stent restenosis represents the major limitation for stenting procedures. In-stent restenosis is the renarrowing o f the artery lumen within a stent predominantly due to excessive growth of neointimal hyperplasia.
Basir, Fariza Fida
core +2 more sources
Safety and efficacy of sirolimus- and paclitaxel-eluting coronary stents. [PDF]
, 2007 BACKGROUND: The safety of drug-eluting stents has been called into question by recent reports of increased stent thrombosis, myocardial infarction, and death.
Kirtane, Ajay J +14 more
core +1 more source
Results of Coronary Stenting for Restenosis
Journal of the American College of Cardiology, 1996 This study attempted to analyze immediate and long-term angiographic and clinical results of coronary stent implantation for restenosis in a consecutive group of patients.The rate of stent utilization in patients with coronary artery disease has increased exponentially in recent years.
COLOMBO, ANTONIO +5 more
openaire +2 more sources
Prevention of Coronary Restenosis [PDF]
Circulation, 2000 Restenosis, the time-limited renarrowing of the lumen of a coronary artery, affects 20% to 40% of patients in the months after an initially successful intervention.1 2 As such, it represents the extreme form of the healing response that produces a normally distributed amount of late loss in lumen diameter at all interventional sites.3 To some extent ...
Richard E. Kuntz, Donald S. Baim
openaire +1 more source
PLoS ONE, 2013 BackgroundCoronary restenosis after percutaneous coronary intervention (PCI) still remains a significant limitation of the procedure. The causative mechanisms of restenosis have not yet been fully identified.
Jeffrey J W Verschuren +9 more
doaj +1 more source
Effects of an alpha-4 integrin inhibitor on restenosis in a new porcine model combining endothelial denudation and stent placement. [PDF]
PLoS ONE, 2010 Restenosis remains the main complication of balloon angioplasty and/or stent implantation. Preclinical testing of new pharmacologic agents preventing restenosis largely rely on porcine models, where restenosis is assessed after endothelial abrasion of ...
Anne Braun +7 more
doaj +1 more source
Genetic variants of the promoter of the heme oxygenase-1 gene and their influence on cardiovascular disease (The Ludwigshafen risk and cardiovascular health study) [PDF]
, 2009 Background Heme oxygenase-1 is an inducible cytoprotective enzyme which handles oxidative stress by generating anti-oxidant bilirubin and vasodilating carbon monoxide.
Hoffmann Michael M +26 more
core +2 more sources
Role of Interleukin-18 in vascular injury: a new pharmacological target for the prevention of restenosis [PDF]
, 2006 Background: Studies in humans as well as in animal models suggest that interleukin-18 (IL-18) plays a crucial role in vascular pathologies. IL-18 is a strong predictor of cardiovascular death in angina and is involved in atherotic plaque destabilization.
Grassia, Gianluca
core +1 more source